During the last 10 days, we enjoyed discussing different aspects of the PREVENT trial including background, methodology and results. We have had though provoking questions with great answers. Based on the results of this trial, there is good evidence that dual therapy is not more effective than therapy alone and we should reconsider adding on IPC for VTE prophylaxis, taking into consideration the population that was included in this trial. Thank you authors for this excellent work.
Sincerely thanks to all who participated residents, faculty and authors. We appreciate everyone that supported this amazing educational experience and we also thank the NEJM group for making this GLOBAL journal club possible. Any final thought is welcome.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.